CME Group Inc. (CME)
CME Group Inc. (CME) Stock Price: $255.94+3.91 (+1.55%)
The total return cagr for CME Group Inc. (CME) stock is -0.89% over the past 12 months. The 3 year average growth rate is 16.35% and the 5 year cagr is 7.94%. Total return includes dividends reinvested.
The closing share price for CME Group Inc. (CME) stock was $255.94 for Tuesday, June 9, 2026, up +1.55% from the previous day.
CME Price Chart
End-of-day pricesAdvanced chart →
CME$255.94▼ -3.82%as of Jun 9, 2026
CME Key Metrics
See All MetricsCME Earnings Preview
Next Earnings Date
Jul 22, 2026
43 days away
EPS Estimate
2.98
Revenue Est.
$1.72B
Last Quarter Results
EPS
$3.36
vs Estimate
$3.37
Met
Revenue
$1.88B
vs Estimate
$1.87B
Met
CME Analyst Ratings
Consensus Rating
Hold
Based on 15 analysts
Strong Buy
4
Buy
3
Hold
6
Sell
1
Strong Sell
2
Average Price Target
$305.47
+19.4% upside
Low
$230.00
Current
$255.94
High
$353.00
CME Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2029 | N/A | $3.72 | N/A | 4 |
| Q2 2029 | N/A | $3.67 | N/A | 4 |
| Q3 2029 | N/A | $3.60 | N/A | 4 |
| Q4 2029 | N/A | $3.46 | N/A | 4 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $12.88 | N/A | 9 |
| FY 2028 | N/A | $13.72 | N/A | 3 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2029 | N/A | $2.06B | N/A | 4 |
| Q2 2029 | N/A | $2.03B | N/A | 4 |
| Q3 2029 | N/A | $2.00B | N/A | 4 |
| Q4 2029 | N/A | $1.97B | N/A | 4 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $7.36B | N/A | 9 |
| FY 2028 | N/A | $7.81B | N/A | 3 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
CME Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1CME | $92.74B | $255.94 | +1.55% | -0.89% | +7.94% | +14.76% |
CME Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt